These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram. Turitto G, Fontaine JM, Ursell S, Caref EB, Bekheit S, el-Sherif N. Am J Med; 1990 Jan; 88(1N):35N-41N. PubMed ID: 2368762 [Abstract] [Full Text] [Related]
7. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB. Am J Cardiol; 1997 Sep 11; 80(5B):3F-9F. PubMed ID: 9291444 [Abstract] [Full Text] [Related]
10. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation. Platia EV, Reid PR. J Am Coll Cardiol; 1984 Sep 11; 4(3):493-500. PubMed ID: 6470328 [Abstract] [Full Text] [Related]
11. Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators. Buxton AE, Lee KL, DiCarlo L, Echt DS, Fisher JD, Greer GS, Josephson ME, Packer D, Prystowsky EN, Talajíc M. Ann Intern Med; 1996 Jul 01; 125(1):35-9. PubMed ID: 8644986 [Abstract] [Full Text] [Related]
12. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias. Kuchar DL, Garan H, Ruskin JN. Am J Cardiol; 1988 Oct 19; 62(12):39H-45H. PubMed ID: 3052008 [Abstract] [Full Text] [Related]
13. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN. Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357 [Abstract] [Full Text] [Related]
14. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies. Rae AP, Greenspan AM, Spielman SR, Sokoloff NM, Webb CR, Kay HR, Horowitz LN. Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1494-9. PubMed ID: 3890509 [Abstract] [Full Text] [Related]
15. Spontaneous arrhythmia detected on ambulatory electrocardiographic recording lacks precision in predicting inducibility of ventricular tachycardia during electrophysiologic study. Pratt CM, Thornton BC, Magro SA, Wyndham CR. J Am Coll Cardiol; 1987 Jul 01; 10(1):97-104. PubMed ID: 3598001 [Abstract] [Full Text] [Related]
16. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease. Manolis AS, Estes NA. Am J Cardiol; 1990 Jan 15; 65(3):201-5. PubMed ID: 2296889 [Abstract] [Full Text] [Related]
18. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group. Kowey PR, Waxman HL, Greenspon A, Greenberg R, Poll D, Kutalek S, Gessman L, Muenz L. Am J Cardiol; 1990 Mar 01; 65(9):594-8. PubMed ID: 2309629 [Abstract] [Full Text] [Related]
20. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. Watson RM, Schwartz JL, Maron BJ, Tucker E, Rosing DR, Josephson ME. J Am Coll Cardiol; 1987 Oct 01; 10(4):761-74. PubMed ID: 3655144 [Abstract] [Full Text] [Related] Page: [Next] [New Search]